VALN News and Press, Valneva SE From 11/29/21

Valneva SE (VALN +8.2%) ADRs are trading sharply higher for the second straight session on the announcement of a partnership with IDT Biologika to produce the company’s inactivated COVID-19 vaccine candidate VLA2001. Per the terms of the deal, IDT Biologika is expected to manufacture t...

Krystal Biotech KRYS +115% says study on VYJUVEKTM for rare skin disease met primary endpoint Petros Pharmaceuticals PTPI +62% 180 Life Sciences, Vaxart gain amid social media buzz; Petros climb over 60% NRx Pharmaceuticals NRXP +48% after Zyesami increased likel...

iSpecimen (NASDAQ:ISPC) +70% COVID-19 vaccine stocks surge on worries over new variant Allied Healthcare Products (NASDAQ:AHPI) +68%. Alpha Pro Tech (NYSE:APT) +24% Zoom Video and Peloton take off as new COVID variant revives stay-at-home trade Valneva SE (NASDAQ:VALN) +18...

Valneva (VALN +4.4%) has signed an Advance Purchase Agreement (APA) with the European Commission for the supply of its inactivated COVID-19 vaccine candidate. The agreement relates to the supply of up to 60M doses of Valneva's VLA2001 vaccine over two years. The EC has the option to increase ...

Valneva (NASDAQ:VALN): 9M Liquid funds increased to €247.9M as of September 30, 2021 compared to €156.2M as of December 31, 2020. Revenue of €69.8M (+18.7% Y/Y) Press Release For further details see: Valneva reports 9M results

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Valneva SE (NASDAQ: VALN) Receives European Commission Approval of Advance Purchase Agreement for its COVID-19 Vaccine VLA2001 ” Valneva SE (NASDAQ: VALN) ...

RenovoRx (NASDAQ:RNXT) +68% after presentation on treatment platform RingCentral (NYSE:RNG) +26% after boosting full-year revenue outlook; buys Mitel's IP rights and patents Valneva SE American Depositary (NASDAQ:VALN) +25% on European nod to procure up to 60M do...

Valneva (NASDAQ:VALN) ADRs are trading ~23.4% higher in the pre-market after the company announced that the European Commission (“EC”) has greenlighted an agreement to purchase 60M doses of the company’s experimental COVID-19 vaccine VLA2001. Per the terms ...

Shares of Dynavax Technologies (NASDAQ:DVAX) are poised to move this week due to two important events. Tomorrow, the CDC's Advisory Committee on Immunization Practices is set to discuss a universal adult hepatitis B vaccine recommendation. Dynavax could benefit with a vote in the affirmative ...

Valneva (NASDAQ:VALN) announced that the underwriters of its global offering of 4.5M shares consisting of a private placement of 4.47M shares in Europe and other countries outside of U.S. It also launched a concurrent public offering of 16.56 ADSs, each representing two ordinary shares; have ...